Terumo Corporation · TSE:4543
Terumo — EuroPCR 2021
5 slides from Terumo's conference presentation, 2021
Slide 1: EuroPCR 2021 Flash Report
EuroPCR 2021 Flash Report
Slide 2: e-Ultimaster: Complete versus incomplete revascularization in NSTEMI patients
e-Ultimaster Complete versus incomplete revascularization in NSTEMI patients “Our findings suggest that a physician- directed complete revascularisation strategy with the Ultimaster stent results in optimised clinical outcomes in this all- comers NSTEMI population” (1 Pieter C. Smits, MD Objective M
Slide 3: e-Ultimaster: First machine learning derived risk score for target lesion failure
e-Ultimaster First machine learning derived risk score for target lesion failure one year after DES implantation “We show the feasibility of adopting machine learning approaches in developing a risk prediction model for 1-year TLF, with superior performance than traditional statistic approaches” (2
Slide 4: CENTURY JSV: Five-year outcomes of small vessel stenting in Japanese population
CENTURY JSV Five-year clinical outcomes after coronary stenting of small vessels in Japanese population using 2.25 mm diameter Sirolimus-eluting stent with bioresorbable polymer “We could certify safety and effectiveness after 2.25mm Ultimaster bioresorbable-polymer sirolimus-eluting stent implantat
Slide 5: Contact us today for any assistance that you may need
Contact us today for any assistance that you may need! Click here